MarketSurge Alternatives: 7 Free & Paid Platforms for 2026

ChartingLens is a well-established AI charting platform with a large active user base, advanced features, an institutional-grade strategy builder, and an institutional-grade backtesting engine. It ranks first here because it replaces most of what a MarketSurge subscriber uses day to day, then adds what MarketSurge never had, at $14.99 a month instead of $149.95.

For the growth screen: its stock screener filters on EPS growth, revenue growth and distance from 52-week highs, alongside the usual technical filters, across the US and ten international markets. Automated pattern recognition flags breakouts, flags and pennants, triangles, wedges and double bottoms on the chart, and the Premium pattern scanner finds them across the market. A fundamentals panel, earnings dates, insider trades from SEC filings and hedge fund 13F holdings (Buffett, Burry, Ackman and more) sit one click from the chart.

Then the parts MarketSurge doesn't do. An AI assistant that reads the chart you're on and draws support and resistance. An institutional-grade strategy builder that turns rules like "buy a breakout above the 50-day high on 1.5x volume, sell 8% below entry" into a test, and an institutional-grade backtesting engine that reports win rate, drawdown and a full trade log. If you have an IBD-style RS rating script from TradingView's community, you can paste the Pine in and it becomes a native indicator, license permitting.

It's multi-asset (stocks, ETFs, crypto, forex, metals and futures charting, all free to chart), broker-agnostic with no platform lock-in, and battle-tested at scale by a large active trader community whose feedback shapes the roadmap. It carries a large built-in indicator library, a mature AI-first feature set, and extensive documentation and learning resources including built-in courses.

If you want MarketSurge's workflow and nothing else, Deepvue is the one-to-one answer, and I'd be misleading you if I said otherwise. It was built for CAN SLIM and growth traders, it has its own 1 to 99 ratings, an RS line, stage analysis, a theme tracker, bar replay, an AI terminal and 80+ trader presets. Its team cites experience with William O'Neil's institutional platform.

$49 a month or $490 a year, about a third of MarketSurge. The limits: US equities only, no custom indicators, and its ratings are its own, so they won't match IBD's numbers. The method behind them isn't published.

TC2000's EasyScan is still one of the fastest scanners in retail, and on Premium and up you can plot earnings, sales and insider ownership right on the chart. Write your own RS formula and growth criteria and it'll run them across the market in seconds.

You build everything yourself, though; there are no ready-made IBD-style ratings and no pattern recognition. Scanning needs Premium ($49.99 a month), data add-ons cost extra, and there's no free trial listed.

Finviz is where a lot of growth traders already pre-screen. Elite adds real-time quotes, alerts and auto-refreshing screens for $39.50 a month or $299.50 a year. The performance columns make a decent stand-in for RS ranking when you sort by them.

Charts are basic, there are no IBD-style earnings overlays, it's US-only, and the Elite trial needs a card.

If the RS rating is the number you actually trade off, StockCharts' SCTR (StockCharts Technical Rank) is the nearest public equivalent, and the education around it is excellent. Plans run $19.95 to $49.95 a month, with US real-time data $9.95 extra.

Fundamental data is thin and the interface shows its age.

Stock Rover goes deeper on fundamentals than anything here: hundreds of metrics, ten-plus years of history, growth and quality scores, and solid portfolio analytics. For the "current earnings" and "annual earnings" parts of CAN SLIM, it's excellent value. I couldn't load its official pricing page; reposted figures run from about $7.99 to $27.99 a month, with a 14-day trial.

The charts are weak and it isn't a breakout-timing tool, so most people pair it with something else.

If you can't live without the real Composite and RS ratings, this is the cheap way to keep them. IBD Digital gives you the ratings, Stock Checkup and the IBD lists for roughly $35 a month or $449 a year (intro offers vary). Leaderboard is the curated-picks product at $69 a month.

It isn't a charting platform, so you'll still chart somewhere else.